U.S. MARKETS FOR ELECTROSURGICAL AND THERMAL ABLATION PRODUCTS

http://www.lifescienceintelligence.com/m...

One of the major advances in surgery is the development of thermally based surgical systems and instrumentation, primarily those that utilize electrosurgery or radiofrequency (RF) as the energy form. Thermal energy is now used in general surgery as a substitute for the knife or scalpel and to enact better hemostasis (control of blood flow). This report describes traditional electrosurgical and thermal ablation products used to divide/cut destroy/ablate or modify tissue.

In 2005, the U.S. market for traditional electrosurgery products, including generators, instruments/accessories, and thermal ligature and specialized products, was estimated at approximately $1 billion. This market is expected to grow at a compound annual rate of approximately 3.9%, reaching nearly $1.2 billion in 2010. General and specialty procedures described in the traditional electrosurgery segment total approximately 17 million procedures annually and are forecast to grow to nearly 20 million in 2010. This area includes open and laparoscopic/minimally invasive general surgery as well as specialty areas, including cardiovascular, cosmetic/reconstructive, neurosurgery, obstetrics and gynecology, arthroscopic/orthopedic and urologic surgery.

The more dynamic thermal necrotic/ablation products segment (defined as including various RF and non-RF based surgical products) was estimated at over $390 million in 2005. This market is expected to grow at a healthy compound annual rate of approximately 11%, reaching more than $650 million in 2010. Specialty procedures in this segment include aesthetics/skin remodeling/vein treatment, benign prostatic hyperplasia (BPH), cancer, gynecologic disorders, spinal disc denervation and urinary incontinence.

The total market for electrosurgical and thermal ablation surgical products is estimated at $1.4 billion in 2005 and is forecast to reach nearly $1.9 billion over the next five years.

This dynamic report from Medtech Insight includes analyses of products, technologies, current and forecast markets, competitors, and opportunities. Covered topics in this report include: electrosurgical generators, argon-based coagulators, electrosurgical pencils and tips, return electrodes, thermal ligation devices, minimally invasive instruments, Coblation devices, and percutaneous RF breast biopsy devices. The thermal necrotic/ablation segment focuses on RF, laser and microwave-based BPH treatment, cancer ablation, endometrial ablation, skin tightening, vein treatment and urinary incontinence treatment, among other emerging technologies.